National Cancer Institute CRO Aviano posted this:CHEMIOTHERAPY: IRINOTECAN DRUG MONITORINGThe effectiveness of many anticancer drugs varies greatly from patient to patient and personalized dosages are required to avoid adverse side effects. The invention provides for the first time an electrochemical method to measure the concentration of the drug Irinotecan in patient's plasma and then to establish the optimal dose, with an on site test readable in real time.
National Cancer Institute CRO Aviano posted this:CHEMIOTHERAPY: IMATINIB DRUG MONITORINGThe effectiveness of many anticancer drugs varies greatly from patient to patient, with risks of incorrect dosages and adverse side effects. The invention provides for the first time an electrochemical method to measure the concentration of the drug Imatinib in patient's plasma and then to establish the optimal dose, with an on site test readable in real time.
LUCIA CORAL posted this:
Knowledge Tranfer Manager at National Cancer Institute CRO Aviano
Montserrat Sole Castellvi posted this:
Project Manager at Knowledge Innovation Market
Consejo Superior de Investigaciones Científicas posted this:Peptide for cancer control linked to IL13RR R α α 2 2 o o v v e e r r e e x x p p r r e e s s s s i i o o n n CSIC has developed a peptide capable of inhibiting the signaling of IL-13 mediated by IL13Rα2. This peptide alone or within a nanoparticle or virus-like particles can be used in a pharmaceutical composition for the treatment of pathologies in which IL13Rα2 is overexpressed. This composition would be useful in the treatment and control of metastasis of colon cancer and other tumors (i.e glioblastoma), as well as in other pathologies such as asthma, atopic dermatitis or fibrosis. Industrial partners are being sought to develop and commercialized the products through a patent licence agreement. An offer for Patent Licensing
Nadiia Kachaput posted this:
Innovation Manager at Ukrainian Laboratories
Technology Transfer Office
Medical University of Łódź posted this:In vivo and in vitro experimental laboratory complexKeeping animals to research projects as well as own cultures. Cytotoxicity of a medical device in the form of an extract using in vitro assays: NRU, MTT, XTT, colony formation. Research projects in the field of neurology, orthopedics, toxicology, experimental surgery, oncology, metabolic and behavioral research (AnyMAZE, Morris pool, the cage of fear, IntelliCage) Conducting studies using GMOs. Training in procedures on laboratory animals. Renting test equipment.
Small and Medium Enterprise
Hygea Salud y Nutrición posted this:Nutritional software which makes automatically personalized diets.Vitadieta is a system of Medical Nutrition Therapy, which makes automatically personalized diets for a wide range of goals (lose weight, healthy diet, sports nutrition, pathologies...). The system could be integrate inside a third-party software, or works online. Vitadieta offers functionalities of cross-selling oriented to franchises, recomending product and services of each franchise with the diets.
Research InstituteView Profile
Germans Trias i Pujol Health Sciences Research Institute posted this:Drug Delivery PlatformColonoscopic procedures have become widespread in recent years since colorectal cancer (CRC) and inflammatory bowel disease (IBD) have become prevalent disorders. Their use has expanded as diagnostic and therapeutic tools in both elective and emergency situations. Colorectal cancer (CRC) is the most common cancer in both men and women. In the case of polypectomy, as in the case of surgery, the stabilization of the primary tumors could allow the use of optimizing chemotherapy and therefore an overall improvement in the treatment of the disease.
Technology Transfer Office
USP Innovation Agency posted this:MULTI-TECHNIQUE MOLECULAR IMAGING AGENTS AND THEIR DIAGNOSTIC KITSThis invention presents formulations of diagnosis nano-agents by multi-technique imaging and also their diagnosis kits based on these formulations. Which ones are able to be concentrated on tumors and indicate their existence and localization by using techniques such as nuclear magnetic resonance imaging, positron emission tomography (PET), PET-CT, SPECT, SPECT/CT, PET/MRI and scintigraphy. Moreover, it eventually can be used as therapeutics agents (radiopharmaceuticals). This invention has as main purpose to confer greater sensitivity on imaging diagnosis techniques.
Universidad de Alicante posted this:A decision support system for melanoma diagnosis.A Spanish Research Group has developed a system to help in the recognition of a melanoma through the visual characteristics of an image of the skin lesion. This system can be used as an automated way to decide the urgency to refer a patient to the dermatologist.
IMIM Institut Recerca Hospital del Mar posted this:A TREATMENT FOR TRIPLE NEGATIVE BREAST CANCERTriple negative breast cancers are tipically associated with por prognosis, due to aggressive tumor phenotype(s), only partial response to chemoterapy and present lack of clinically established targeted therapies and respresent the focus of increasing interest at the clinical, biological and epidemiological level, as disclosed in Podo et al., Triple –negative breast cancer: Present challenges and new perspectives, Mol. Oncol., 2010, 4, 209-229. There is, thus, a particular need for new active agents suitable for breast cancer treatment, and in particular need for triple negative breast cancers.